Birch pollen allergen extract - AllergopharmaAlternative Names: AL-0206st
Latest Information Update: 05 Apr 2013
At a glance
- Originator Biomay
- Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 05 Apr 2013 No development reported - Phase-II for Seasonal allergic rhinitis in Germany (Sublingual)